samedan logo
 
 
 
spacer
home > pmps > summer 2008 > rfid to the rescue
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

RFID to the Rescue

During the development process of new therapeutic approaches, multi-phase clinical research studies (clinical trials) are the last hurdle to overcome. Hence clinical trials represent one of the crucial steps in the development of a new drug. In view of increasing competition, rising cost pressures and, above all, the need to bring new products to market as quickly as possible, the current process of clinical trial supply management harbours inefficiencies, which can be eliminated by innovative RFID-based technologies.

‘TIME TO MARKET’ IS CRUCIAL

The total costs of developing a new drug or treatment up to the point of approval can amount to as much as US$ 1 billion. Typically, a new drug will have been subjected to around 10 years of stringent preclinical testing before entering the first of a total of three clinical trial phases. Nonetheless, according to information published by the FDA in 2004, a new drug has merely an eight per cent chance of achieving final approval and thus being brought to market. One of the reasons for this is the fact that results obtained in animal tests can be applied to humans only to a limited extent: around 90 per cent of substances found to be safe with lab animals fail the test of subsequent clinical trials on humans.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Guido Moosmann is Business Development Director RFID at Schreiner MediPharm, one of the major divisions of Schreiner Group based in Oberschleissheim near Munich, Germany. Guido has extensive academic and industry experience in the field of RFID technologies. He is the author and co-author of various studies and books on source tagging and RFID standards.
spacer
Guido Moosmann
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

New IATA Guidance Prepares for Global Vaccine Distribution

The International Air Transport Association (IATA) released guidance to ensure that the air cargo industry is ready to support the large-scale handling, transport and distribution of a COVID-19 vaccine. IATA’s Guidance for Vaccine and Pharmaceutical Logistics and Distribution provides recommendations for governments and the logistics supply chain in preparation for what will be the largest and most complex global logistics operation ever undertaken.
More info >>

White Papers

What is process characterization?

EXPUTEC

Process characterization is an essential step in the commercialization of a new (biological) drug. For drug product commercialization, manufacturers must validate the drug’s manufacturing process. This ensures that the manufacturing process delivers consistently a quality product and that the patient is not at risk.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement